Biogen Drops Alzheimer’s Drug Aduhelm, Ending a 17-year Chapter
(Reuters) -Biogen will end a post-approval study of Alzheimer's treatment Aduhelm and return the licensing rights on the drug after ...
Read moreDetails
Tag: Biogen
The Earth News is an independent English-language daily published Website from all around the World News
